W. A. Groenewegen

发表

A Comparison of the Effects of an Extract of Feverfew and Parthenolide, a Component of Feverfew, on Human Platelet Activity In‐vitro

S. Heptinstall, W. A. Groenewegen, W. A. GROENEWEGEN, 1990, The Journal of pharmacy and pharmacology.

Progress in the medicinal chemistry of the herb feverfew.

S. Heptinstall, D. Knight, W. A. Groenewegen, 1992, Progress in medicinal chemistry.

Na+ channel mutation leading to loss of function and non-progressive cardiac conduction defects.

Lucas J Herfst, H. Jongsma, D. Escande, 2003, Journal of molecular and cellular cardiology.

cDNA and deduced amino acid sequence of a novel cytochrome P-450 from female rat liver mRNA with high homology to P-450 IIC family.

C. Wolf, K. Suckling, W. A. Groenewegen, 1990, Nucleic acids research.

Apolipoprotein B-38.9 does not associate with apo[a] and forms two distinct HDL density particle populations that are larger than HDL.

E. Krul, G. Schonfeld, M. Averna, 1994, Journal of lipid research.

Genomic organization of the rat connexin40 gene: identical transcription start sites in heart and lung.

H. Jongsma, T. V. van Veen, W. A. Groenewegen, 1998, Cardiovascular research.

Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups

S. Heptinstall, W. A. Groenewegen, P. Spangenberg, 1987, The Journal of pharmacy and pharmacology.

Congenital atrial standstill associated with coinheritance of a novel SCN5A mutation and connexin 40 polymorphisms.

N. Makita, H. Yokoshiki, H. Tsutsui, 2005, Heart rhythm.

A novel LQT3 mutation implicates the human cardiac sodium channel domain IVS6 in inactivation kinetics.

H. Jongsma, C. Bezzina, A. Wilde, 2003, Cardiovascular research.

Letter regarding article by McNair et al, "SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia".

A. Wilde, A. Wilde, W. A. Groenewegen, 2005, Circulation.

Polymorphisms in human connexin40 gene promoter are associated with increased risk of hypertension in men

J. Ruijter, H. Jongsma, W. Spiering, 2006, Journal of hypertension.

Sesquiterpene lactones from feverfew, Tanacetum parthenium: isolation, structural revision, activity against human blood platelet function and implications for migraine therapy

M. Hewlett, S. Heptinstall, D. Knight, 1996 .

Compounds extracted from feverfew that have anti‐secretory activity contain an α‐methylene butyrolactone unit

S. Heptinstall, D. Knight, W. A. Groenewegen, 1986, The Journal of pharmacy and pharmacology.

A Cardiac Sodium Channel Mutation Cosegregates With a Rare Connexin40 Genotype in Familial Atrial Standstill

H. Jongsma, L. Sandkuijl, C. Bezzina, 2003, Circulation research.

AMOUNTS OF FEVERFEW IN COMMERCIAL PREPARATIONS OF THE HERB

S. Heptinstall, W. A. Groenewegen, W. Groenewegen, 1986, The Lancet.

Dysbetalipoproteinemia in a kindred with hypobetalipoproteinemia due to mutations in the genes for ApoB (ApoB-70.5) and ApoE (ApoE2).

E. Krul, G. Schonfeld, M. Averna, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

Apolipoprotein B-52 mutation associated with hypobetalipoproteinemia is compatible with a misaligned pairing deletion mechanism.

E. Krul, G. Schonfeld, W. A. Groenewegen, 1993, Journal of lipid research.

Characterization of the rat connexin40 promoter: two Sp1/Sp3 binding sites contribute to transcriptional activation.

H. Jongsma, S. V. van Amersfoorth, W. A. Groenewegen, 2000, Cardiovascular research.

Association of Human Connexin40 Gene Polymorphisms With Atrial Vulnerability as a Risk Factor for Idiopathic Atrial Fibrillation

R. Hauer, H. Jongsma, H. Ramanna, 2004, Circulation research.

Altered Pattern of Connexin40 Distribution in Persistent Atrial Fibrillation in the Goat

M. Allessie, H. Jongsma, W. A. Groenewegen, 1998, Journal of cardiovascular electrophysiology.

Cx40 polymorphism in human atrial fibrillation.

R. Hauer, H. Jongsma, H. Ramanna, 2006, Advances in cardiology.

AN EXTRACT OP FEVERFEW INHIBITS INTERACTION OP HUMAN PLATELETS WITH COLLAGEN SUBSTRATES

S. Heptinstall, V. Repin, W. A. Groenewegen, 1987, Thrombosis and Haemostasis.

Gene polymorphisms and cardiac arrhythmias.

W. A. Groenewegen, M. Firouzi, W. Groenewegen, 2003, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome.

I. V. Van Gelder, A. Wilde, M. Rook, 1999, Cardiovascular research.

Effects of an extract of feverfew (Tanacetum parthenium) on arachidonic acid metabolism in human blood platelets.

S. Heptinstall, W. A. Groenewegen, S. Krause, 1988, Biomedica biochimica acta.

Compound Heterozygosity for Mutations (W156X and R225W) in SCN5A Associated With Severe Cardiac Conduction Disturbances and Degenerative Changes in the Conduction System

Lucas J Herfst, H. Jongsma, C. Bezzina, 2003, Circulation research.

Heterogeneous Connexin43 distribution in heart failure is associated with dispersed conduction and enhanced susceptibility to ventricular arrhythmias

M. Vos, M. Stein, A. Linnenbank, 2010, European journal of heart failure.

The Other End of the Spectrum: Hypobetalipoproteinemia

E. Krul, G. Schonfeld, K. Parhofer, 1993 .